Interferon β-1b retinopathy during a treatment for multiple sclerosis

被引：0
|
作者：
Sommer, S [1 ]
Sablon, JC [1 ]
Zaoui, M [1 ]
Rozot, P [1 ]
Hosni, A [1 ]
机构：
[1] CHR ND Bonsecours, F-57038 Metz 1, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2001年 / 24卷 / 05期
关键词：
interferon; multiple sclerosis; cotton wool spots; retinopathy;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Ocular adverse effects of interferon are described during the treatment of malignant diseases and chronic viral hepatitis with interferon alpha. At this time, there is no report of these effects during multiple sclerosis treatment with interferon beta -1b. The authors report a bilateral retinopathy during this treatment. The production of neutralizing antibodies during interferon beta -1b treatment leads to a decreese in diminution of therapeutic efficacy. When treatment failure occurs, neutralizing antibodies are to be tested.
引用
收藏
页码：509 / 512
页数：4
相关论文
共 50 条
  • [41] Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis
    Modrego, P. J.
    Gazulla, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1655 - 1656
  • [42] Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b
    Narayanan, S
    De Stefano, N
    Francis, GS
    Arnaoutelis, R
    Caramanos, Z
    Collins, DL
    Pelletier, D
    Arnason, BGW
    Antel, JP
    Arnold, DL
    JOURNAL OF NEUROLOGY, 2001, 248 (11) : 979 - 986
  • [43] Nephrotic syndrome associated with interferon-β-1b therapy for multiple sclerosis
    Kumasaka R.
    Nakamura N.
    Shirato K.
    Fujita T.
    Murakami R.
    Shimada M.
    Nakamura M.
    Osawa H.
    Yamabe H.
    Okumura K.
    Clinical and Experimental Nephrology, 2006, 10 (3) : 222 - 225
  • [44] Neutralizing antibodies to interferon β-1b are not associated with disease worsening in multiple sclerosis
    Goodin, D. S.
    Hurwitz, B.
    Noronha, A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (01) : 208 - 210
  • [45] The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b
    Rice, GPA
    Paszner, B
    Oger, J
    Lesaux, J
    Paty, D
    Ebers, G
    NEUROLOGY, 1999, 52 (06) : 1277 - 1279
  • [46] Stabilisation under Interferon β-1b in Late-Onset Multiple Sclerosis
    Lindquist, S.
    Stangel, M.
    AKTUELLE NEUROLOGIE, 2012, 39 : S31 - S33
  • [47] A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis
    Albani, C
    Albani, G
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04): : 418 - 418
  • [48] Retinopathy secondary to treatment with interferon beta-1a in a patient with multiple sclerosis
    Mallada-Frechín, J
    Abellin-Miralles, I
    Alfaro-Beltra, ML
    Medrano, V
    Muñoz-Gil, MB
    Fernández-Izquierdo, S
    Piqueras-Rodríguez, L
    REVISTA DE NEUROLOGIA, 2005, 40 (08) : 482 - 484
  • [49] Autoimmune events during interferon beta-1b treatment for multiple sclerosis
    Durelli, L
    Ferrero, B
    Oggero, A
    Verdun, E
    Bongioanni, MR
    Gentile, E
    Isoardo, GL
    Ricci, A
    Rota, E
    Bergamasco, B
    Durazzo, M
    Saracco, G
    Biava, MA
    Brossa, PC
    Giorda, L
    Pagni, R
    Aimo, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 162 (01) : 74 - 83
  • [50] New onset of rheumatoid arthritis during interferon β-1B treatment in a patient with multiple sclerosis:: comment on the case report by Jabaily and Thompson
    Alsalameh, S
    Manger, B
    Kern, P
    Kalden, J
    ARTHRITIS AND RHEUMATISM, 1998, 41 (04): : 754 - 754
12345